Medicare Enrolled
Dr. Sharon Scherl, M.D.
Dermatology · Tenafly, NJ
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Scherl from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Scherl?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Scherl
Dr. Sharon Scherl is a dermatology specialist in Tenafly, NJ, with 20 years of NPI registration. Based on federal Medicare data, Dr. Scherl performed 11,533 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Scherl received a total of $81,532 from 48 pharmaceutical and/or device companies across 1079 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Scherl is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 4% volume in NJ
$81,532 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗11,533
Medicare services
Top 4% in NJ for dermatology
Not available
Unique patients (not deduplicated)
$30
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Photodynamic therapy gel for precancerous skin | 4,002 | $1 | $5 |
| Destruction of precancerous skin growths, 2-14 This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer. |
2,783 | $6 | $25 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,429 | $72 | $299 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
994 | $46 | $191 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
835 | $49 | $236 |
| Skin biopsy, tangential A procedure to remove a sample of the first identified skin growth for laboratory examination. |
656 | $85 | $357 |
| Additional skin growth biopsy Removal of a sample of an additional skin growth for laboratory examination. This code is used for each extra lesion biopsied during the same session. |
169 | $47 | $176 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
140 | $90 | $374 |
| New patient office visit, 15-29 minutes An initial office visit for a new patient lasting 15 to 29 minutes. This code is used when the total time spent on the date of the encounter meets this duration threshold. |
77 | $62 | $245 |
| Destruction of skin growths (warts/lesions), 1-14 This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface. |
71 | $100 | $404 |
| Destruction of cancer skin growth, 1.1-2.0 cm Removal of a cancerous skin growth on the trunk, arms, or legs that measures between 1.1 and 2.0 centimeters. |
68 | $151 | $616 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
40 | $102 | $424 |
| Injection into skin growths, 1-7 A procedure involving the injection of medication into one to seven skin growths. |
29 | $36 | $201 |
| Ear tissue biopsy A procedure to remove a small sample of tissue from the ear for laboratory examination. |
28 | $62 | $337 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
28 | $1 | $4 |
| Punch biopsy of first skin growth A small, circular piece of skin is removed from a skin growth using a circular blade. The sample is then sent to a laboratory for examination. |
27 | $114 | $442 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
27 | $12 | $48 |
| Destruction of cancer skin growth on trunk, arms, or legs, 0.5 cm or less This procedure involves the removal or destruction of a cancerous skin growth located on the trunk, arms, or legs that is 0.5 centimeters or smaller in size. |
24 | $72 | $351 |
| Light application with debridement to destroy precancerous skin growth This procedure involves applying light to the skin along with debridement to destroy precancerous skin growths. |
20 | $232 | $1,000 |
| Intermediate wound repair, 2.6-7.5 cm A medical procedure to close a wound on the scalp, underarms, trunk, arms, or legs that measures between 2.6 and 7.5 centimeters. This type of repair involves cleaning the wound and stitching it closed to promote healing. |
19 | $284 | $1,062 |
| Destruction of cancerous skin growth on face, 1.1-2.0 cm This procedure involves the removal or destruction of a cancerous skin lesion located on the face, ears, eyelids, nose, lips, or mouth. The lesion treated measures between 1.1 and 2.0 centimeters in diameter. |
19 | $166 | $710 |
| Simple drainage of skin abscess A minor procedure to drain a localized collection of pus from the skin. The abscess is opened to allow the fluid to escape and promote healing. |
16 | $115 | $421 |
| Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | 16 | $170 | $655 |
| Destruction of small cancerous skin growth on face or mouth This procedure involves the removal or destruction of a cancerous skin lesion measuring 0.5 centimeters or less located on the face, ears, eyelids, nose, lips, or mouth. |
16 | $114 | $488 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$81,532
Total received (2018-2024)
Avg $11,647/year across 7 years
Top 6% in NJ for dermatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
48
Companies
1,079
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$33,224
2023
$30,013
2022
$3,498
2021
$9,120
2020
$3,540
2019
$1,137
2018
$1,001
Payments by company (2024)
Dermavant Sciences, Inc.
$29,761
PFIZER INC.
$510
ABBVIE INC.
$462
Janssen Biotech, Inc.
$406
UCB, Inc.
$385
SUN PHARMACEUTICAL INDUSTRIES INC.
$361
GENZYME CORPORATION
$341
Lilly USA, LLC
$255
Arcutis Biotherapeutics, Inc.
$227
Amgen Inc.
$180
E.R. Squibb & Sons, L.L.C.
$67
Verrica Pharmaceuticals Inc.
$55
Galderma Laboratories, L.P.
$53
Novartis Pharmaceuticals Corporation
$47
Incyte Corporation
$34
LEO Pharma Inc.
$34
Ortho Dermatologics, a division of Bausch Health US, LLC
$32
Regeneron Healthcare Solutions, Inc.
$16
Top 3 companies account for 92.5% of 2024 payments
All-time payments by company (2018-2024) ›
Dermavant Sciences, Inc.
$55,371
VYNE Pharmaceuticals Inc.
$9,949
EPI Health, LLC
$1,661
Incyte Corporation
$1,472
Janssen Biotech, Inc.
$1,268
Lilly USA, LLC
$1,047
Sun Pharmaceutical Industries Inc.
$895
PFIZER INC.
$866
Galderma Laboratories, L.P.
$708
ABBVIE INC.
$702
GENZYME CORPORATION
$670
LEO Pharma Inc.
$652
Ortho Dermatologics, a division of Bausch Health US, LLC
$648
Amgen Inc.
$634
UCB, Inc.
$546
AbbVie Inc.
$537
Novartis Pharmaceuticals Corporation
$485
SUN PHARMACEUTICAL INDUSTRIES INC.
$444
Regeneron Healthcare Solutions, Inc.
$433
Arcutis Biotherapeutics, Inc.
$402
MAYNE PHARMA INC.
$295
E.R. Squibb & Sons, L.L.C.
$288
Journey Medical Corporation
$287
Mayne Pharma Inc.
$170
Biofrontera Inc.
$148
Genentech USA, Inc.
$138
Almirall LLC
$132
Celgene Corporation
$96
Verrica Pharmaceuticals Inc.
$70
Sandoz Inc.
$62
AbbVie, Inc.
$55
Allergan, Inc.
$47
Boehringer Ingelheim Pharmaceuticals, Inc.
$47
DERMIRA, INC.
$43
Promius Pharma LLC
$43
Encore Dermatology Inc.
$41
Sebela Pharmaceuticals Inc.
$30
Helsinn Therapeutics (U.S.), Inc.
$15
Taro Pharmaceuticals USA, Inc.
$15
Exeltis, USA Inc.
$15
TARO PHARMACEUTICALS USA, INC.
$15
Kyowa Kirin, Inc.
$15
Glenmark Therapeutics Inc.
$14
Solta Medical, a division of Bausch Health US, LLC
$14
SANOFI-AVENTIS U.S. LLC
$13
Mylan Pharmaceuticals Inc.
$13
Pierre Fabre Pharmaceuticals, Inc.
$12
MAYNE PHARMA COMMERCIAL LLC
$10
Top 3 companies account for 82.2% of all-time payments
Associated products mentioned in payments ›
ABSORICA · ABSORICA (isotretinoin) · ABSORICA LD · ADBRY · AKLIEF · AMELUZ · AMZEEQ · APEXICON E · ARAZLO · Absorica LD · Aczone · Ameluz · BLU-U · BOTOX · BOTOX COSMETIC · BRYHALI · Bensal HP · Bimzelx · CIBINQO · CLODERM · COSENTYX · Cabtreo · Cimzia · Cordran Tape · DERMATITIS - DISEASE · DORYX · DUOBRII · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · EBGLYSS · ELIDEL · ENSTILAR · EPIDUO FORTE · EPSOLAY · EUCRISA · Ecoza · Enbrel · Erivedge · FINACEA · HUMIRA · Humira · ILUMYA · ILUMYA (tildrakizumab-asmn) injection · Ilumya · Impoyz · JUBLIA · JUBLIA EFINACONAZOLE · KERYDIN · Klisyri · LEVULAN KERASTICK · LIBTAYO · LITFULO · LUZU LULICONAZOLE · Mupirocin Cream · NAFTIN · ODOMZO · OLUMIANT · ONEXTON · OPZELURA · ORACEA · OXISTAT · Odomzo · Olux · Otezla · PICATO · POTELIGEO · PRAMOSONE · QBREXZA · REMICADE · RINVOQ · SILIQ · SKYRIZI · SOOLANTRA · SPEVIGO · Seysara · Sitavig · Sotyktu · TALTZ · TREMFYA · TRIANEX 0.05% · TargaDox · Tremfya · Trianex · ULTRAVATE · VALCHLOR · VTAMA · WYNZORA · Winlevi · XIMINO · Xolegel · YCANTH · ZILXI · Zoryve
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Dermatologists in nearby ZIP areas
987
County median income
$123,715
Nearest hospital to ZIP centroid (approximate)
ENGLEWOOD HOSPITAL AND MEDICAL CENTER
2.2 mi
2.2 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Scherl is a clinical cardiology specialist, with above-average Medicare volume (top 4% in NJ), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Scherl experienced with photodynamic therapy gel for precancerous skin?
Based on Medicare claims data, Dr. Scherl performed 4,002 photodynamic therapy gel for precancerous skin services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Scherl receive payments from pharmaceutical companies?
Yes. Dr. Scherl received a total of $81,532 from 48 companies across 1,079 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Scherl's costs compare to other dermatologists in Tenafly?
Dr. Scherl's average Medicare payment per service is $30. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Scherl) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Dermatologists in Tenafly
Browse dermatologists in Tenafly ranked by procedure volume and transparency data.
Highest volume
Top Dermatologists in NJ
Dermatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Dermatologists in NJ
Which NJ dermatologists receive the most from drug and device companies.
By company
Dermavant Sciences, Inc. Payments to Doctors
See all physicians who received payments from Dermavant Sciences, Inc.
By company
VYNE Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from VYNE Pharmaceuticals Inc.
By company
EPI Health, LLC Payments to Doctors
See all physicians who received payments from EPI Health, LLC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology